Widecells Share Discussion Threads

[leader11] 07/11/2018 15:05

What from issued shares?

[1bluehorseshoe] 07/11/2018 14:10

Should only be 5m remaining

[leader11] 07/11/2018 08:59

Sorry this one is INDUS. Appolgies. https://youtu.be/KaBz9nHyhjM

[leader11] 07/11/2018 08:54

New technology INDUS.https://youtu.be/-az6NP4PY1o

[tomboyb] 06/11/2018 15:41

10 Million shares issued at par -

Can't go any lower -

sh*t deal what management have on offer -

[tomboyb] 06/11/2018 13:05

That was quick -

[tomboyb] 06/11/2018 13:04

1 v 1 -

Will break upwards -

[leader11] 06/11/2018 11:50

Maybe they have completed the cellplan in Spain and rollout in the UK now.

[leader11] 06/11/2018 11:33

Something is definitely positive going on here.

[leader11] 06/11/2018 10:04

I'm just trying to figure more out about Biovault. It really looks good on the insurance side of things could even have an insurance company as well who knows. Jmo.

[leader11] 06/11/2018 10:01

It's all on YouTube and previous rns.

[1bluehorseshoe] 06/11/2018 09:36

Looks like someone has been reading your research Leader

[leader11] 04/11/2018 20:24

https://www.medgadget.com/2018/10/top-10-stem-cell-therapy-market-players-size-and-shares-forecasts-till-2023-mrfr.htmlRegional AnalysisEurope (UK, Belgium, France, and Netherlands) is the second largest global stem cell therapy market during the forecast period. The increasing occurrence of stroke, cancer, and osteoarthritis drives the market in this region. According to Anthony Nolan organization 2017, annual review 1.4million people register for donating stem cell in 2017. Also, more than 2,200 searches for a lifesaving stem cell transplant were made in 2017 by UK people. Such a high demand for Stem cell transplantation in this region promotes the market.

[leader11] 04/11/2018 19:35

https://surelygroup.com/cellplan-selects-surely-to-power-its-quote-buy-platform/CellPlan selects Surely to power its Quote & Buy platformMar 2017CellPlan has selected Surely's Quote and Buy platform to underpin its international rollout. CellPlan is part of the WideCells Group, the Worldwide Provider of Stem Cell Services that listed on the LSE last year (EPIC:WDC). The group is leading a transformation in cord blood banking and stem cell treatment, making cord blood banking more accessible through insurance coverage, and increasing the availability of cord blood for transplants. CellPlan, one of its 3 divisions, provides the first global stem cell treatment insurance plan, unlocking the potential of cord blood banking.After conducting a review of the market, CellPlan selected Surely to provide its Quote and Buy system, allowing customers to obtain a quote online, purchase CellPlan, and obtain all the relevant documentation. Back-end checks with the core blood bank partners will also be handled by the platform. The solution will be launched initially in the UK, and will then be rolled out to international countries over the next 18 months, with additional product lines anticipated too.Joao Andrade, CEO of WideCells Group, said: "Having successfully established the world's first stem cell insurance plan, CellPlan, we are now focussed on promoting global uptake of this potentially life-saving product. To support this, we wanted a modern platform built on the latest technology, that can support customers purchasing our policies in the easiest possible way, with a strong focus on a clean and attractive user journey, support for all devices, and the ability to scale rapidly to multiple countries, currencies and languages. We are delighted to be working with Surely to achieve this and have been impressed with Surely's mission to power digital insurance via their technology, their responsiveness and agility. In line with our fast paced development approach, we expect to launch our UK site within just 6 weeks of signing our contract with Surely and look forward to the significant opportunities ahead."Larry Shapiro, CEO of Surely, said: "We are delighted to have CellPlan as our newest customer, benefitting from the substantial investment we have made over the past 3 years into designing and building a flexible Quote and Buy cloud-based platform for the insurance industry. We are inspired by CellPlan's ambitious vision for insurance to support stem cell treatments, and by their wider vision for the WideCells Group".

[leader11] 04/11/2018 19:17

WideCells reports significant early interest in CellPlan in SpainShare 11:54 31 Jul 2018Joao Andrade, chief executive of WideCells Group PLC (LON:WDC), discusses with Proactive's Andrew Scott the launch of their innovative insurance product CellPlan in Spain.It follows a soft roll-out of CellPlan via partner Stem Cell Banco Celulas Madre, a storage service specialist.Spain is one of Europe's most developed cord blood and stem cell storage markets.From proactive investors.

[leader11] 04/11/2018 19:15

Cellplan in SpainStem Cell Banco Celulas Madrehttp://www.bancostemcell.com/en/mlb-group/

[leader11] 02/11/2018 00:47

https://www.youtube.com/watch?v=D3FB2uglbjk&feature=share

[leader11] 02/11/2018 00:41

https://www.youtube.com/watch?v=9xHxIPszELM&feature=share

[leader11] 02/11/2018 00:33

Milton has now increased its share beyond 10 percent don't mention by how much.